Calidi Biotherapeutics Revenue

Revenue (ttm)

n/a

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

Market Cap

2.75M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	-	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	45.00K	-404.00K	-89.98%
Dec 31, 2021	449.00K	-	-
Dec 31, 2020	-	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Jaguar Health	11.79M
60 Degrees Pharmaceuticals	1.36M
Scinai Immunotherapeutics	1.15M
PMGC Holdings	285.95K
Azitra	7.50K

Revenue Rankings

CLDI News

3 days ago - Calidi Biotherapeutics Announces Pricing of $5.2 Million Underwritten Public Offering - GlobeNewsWire
3 days ago - Calidi Biotherapeutics Announces Proposed Public Offering - GlobeNewsWire
17 days ago - Calidi Biotherapeutics Presents Data on its New Approach to Bispecific T-Cell Engagers (BiTEs) Using its RedTail Platform at the 2026 AACR-IO Conference - GlobeNewsWire
25 days ago - Calidi Biotherapeutics To Present on its New Approach to Bispecific T-Cell Engagers (BiTEs) Using its RedTail Platform in a Late-Breaking Abstract at the 2026 AACR-IO Conference - GlobeNewsWire
4 months ago - Calidi Biotherapeutics Announces Exclusive Live Investor Webinar and Q&A Session on November 19, 2025 - GlobeNewsWire
4 months ago - Calidi Biotherapeutics Reports Third Quarter 2025 Financial Results and Recent Operational Highlights - GlobeNewsWire
7 months ago - Calidi Biotherapeutics Announces Closing of $6.9 Million Underwritten Public Offering and Full Exercise of Underwriters' Over-Allotment Option - GlobeNewsWire
7 months ago - Calidi Biotherapeutics Announces Pricing of $6 Million Underwritten Public Offering - GlobeNewsWire

More News